Despite the development of numerous cancer treatment technologies, the common goal of current cancer therapies is to eliminate cancer cells. This approach, however, faces fundamental limitations, ...

These regulators are known as MYB, HDAC2, and FOXA2 and when they were suppressed in colon cancer cells, the cells switched back to a normal-like state, removing the cancer threat without destroying ...

A research team has developed a groundbreaking technology that can treat colon cancer by converting cancer cells into a state resembling normal colon cells without killing them, thus avoiding side ...

In a trailblazing advancement in cancer therapy, researchers at Korea Advanced Institute of Science and Technology (KAIST) have developed a technology that transforms colon cancer cells into ...

Russell has a PhD in the history of medicine, violence, and colonialism. His research has explored topics including ethics, science governance, and medical involvement in violent contexts. Russell has ...

KAIST (Korea Advanced Institute of Science and Technology), under the leadership of President Kwang Hyung Lee, unveiled a groundbreaking innovation. A research team led by Professor Kwang-Hyun Cho ...

All currently used cancer treatment methods aim to destroy cancer cells. However, they have inherent limitations, including the possibility of cancer cells acquiring resistance and recurring or ...

Researchers have developed a new groundbreaking technology that can convert some cancer cells into a state that resembles normal cells without killing them. This approach not only represents a new way ...

In the post-genomic era, long non-coding RNAs (lncRNAs) have emerged as critical regulators in various cancers and hold potential as minimally invasive diagnostic biomarkers. This study aimed to ...

A new study from researchers at The University of Texas MD Anderson Cancer Center finds that, in healthy women, some breast cells that otherwise appear normal may contain chromosome abnormalities ...